Organization of the Caenorhabditis Elegans Small Non-Coding Transcriptome: Genomic Features, Biogenesis, and Expression
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Mrna Vaccine Era—Mechanisms, Drug Platform and Clinical Prospection
International Journal of Molecular Sciences Review mRNA Vaccine Era—Mechanisms, Drug Platform and Clinical Prospection 1, 1, 2 1,3, Shuqin Xu y, Kunpeng Yang y, Rose Li and Lu Zhang * 1 State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Science, Fudan University, Shanghai 200438, China; [email protected] (S.X.); [email protected] (K.Y.) 2 M.B.B.S., School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China; [email protected] 3 Shanghai Engineering Research Center of Industrial Microorganisms, Shanghai 200438, China * Correspondence: [email protected]; Tel.: +86-13524278762 These authors contributed equally to this work. y Received: 30 July 2020; Accepted: 30 August 2020; Published: 9 September 2020 Abstract: Messenger ribonucleic acid (mRNA)-based drugs, notably mRNA vaccines, have been widely proven as a promising treatment strategy in immune therapeutics. The extraordinary advantages associated with mRNA vaccines, including their high efficacy, a relatively low severity of side effects, and low attainment costs, have enabled them to become prevalent in pre-clinical and clinical trials against various infectious diseases and cancers. Recent technological advancements have alleviated some issues that hinder mRNA vaccine development, such as low efficiency that exist in both gene translation and in vivo deliveries. mRNA immunogenicity can also be greatly adjusted as a result of upgraded technologies. In this review, we have summarized details regarding the optimization of mRNA vaccines, and the underlying biological mechanisms of this form of vaccines. Applications of mRNA vaccines in some infectious diseases and cancers are introduced. It also includes our prospections for mRNA vaccine applications in diseases caused by bacterial pathogens, such as tuberculosis. -
Small RNA Fragments Derived from Multiple RNA Classes – the Missing
Jackowiak et al. BMC Genomics (2017) 18:502 DOI 10.1186/s12864-017-3891-3 RESEARCHARTICLE Open Access Small RNA fragments derived from multiple RNA classes – the missing element of multi-omics characteristics of the hepatitis C virus cell culture model Paulina Jackowiak1, Anna Hojka-Osinska1, Anna Philips1, Agnieszka Zmienko1,2, Lucyna Budzko1, Patrick Maillard3, Agata Budkowska3,4 and Marek Figlerowicz1,2* Abstract Background: A pool of small RNA fragments (RFs) derived from diverse cellular RNAs has recently emerged as a rich source of functionally relevant molecules. Although their formation and accumulation has been connected to various stress conditions, the knowledge on RFs produced upon viral infections is very limited. Here, we applied the next generation sequencing (NGS) to characterize RFs generated in the hepatitis C virus (HCV) cell culture model (HCV-permissive Huh-7.5 cell line). Results: We found that both infected and non-infected cells contained a wide spectrum of RFs derived from virtually all RNA classes. A significant fraction of identified RFs accumulated to similar levels as miRNAs. Our analysis, focused on RFs originating from constitutively expressed non-coding RNAs, revealed three major patterns of parental RNA cleavage. We found that HCV infection induced significant changes in the accumulation of low copy number RFs, while subtly altered the levels of high copy number ones. Finally, the candidate RFs potentially relevant for host-virus interactions were identified. Conclusions: Our results indicate that RFs should be considered an important component of the Huh-7.5 transcriptome and suggest that the main factors influencing the RF biogenesis are the RNA structure and RNA protection by interacting proteins. -
Explore the RNA Universe!
Explore the RNA Universe! Circulating cell-free RNA (ccfRNA) Exosomes Exosomal RNA (exRNA) Ribonuclease P (RNase P) Small (short) interfering RNA (siRNA) Pre-miRNA Small nucleolar RNA Exportin-5 (snoRNA) MicroRNA (miRNA) Drosha Pri-miRNA RISC DGCR8 Ribosomal RNA (rRNA) Small nuclear RNA Ribonuclease MRP Y RNA (snRNA) (RNase MRP) Long non-coding RNA Messenger RNA (mRNA) (IncRNA) Transfer RNA (tRNA) Telomerase RNA Ribosomes Signal recognition particle RNA (SRP RNA) Mitochondria Piwi-interacting RNA (piRNA) Sample to Insight Explore the RNA Universe! RNA function RNA type Detailed role in the cell Protein synthesis Messenger RNA (mRNA) Carrying the genetic information copied from DNA in the form of three-nucleotide bases “codon,” each specifying a particular amino acid for protein synthesis at the ribosomes. Purify with: RNeasy® Plus Kits*, RNeasy Kits*, QIAamp® RNA Blood Kit*, QIAcube® Assay using: QuantiNova® Kits, RT2 Profiler™ PCR Assays and Arrays, Rotor-Gene® Q , QIAseq™ Targeted RNA Panels, QIAseq Stranded mRNA Select Library Kit, QIAseq UPX 3' Targeted RNA Panel, QIAseq UPX 3' Transcriptome RNA Library Kit, QIAseq Targeted RNAscan Panels, QIAseq FX Single Cell RNA Library Kit Transfer RNA Adapter molecule bringing the amino acid corresponding to a specific mRNA codon to the ribosome. Having an anticodon (complementary to the codon), a site (tRNA) binding a specific amino acid and a site binding aminoacyl-tRNA synthetase (enzyme catalyzing amino acid-tRNA binding). Ribosomal RNA (rRNA) RNA component of the ribosome, where protein is translated. Ribosomes align the anticodon of tRNA with the mRNA codon and are required for the peptidyl transferase activity catalyzing the assembly of amino acids into protein chains. -
Deep Evolutionary Origin of Nematode SL2 Trans-Splicing Revealed by Genome-Wide
bioRxiv preprint doi: https://doi.org/10.1101/642082; this version posted May 27, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. Deep evolutionary origin of nematode SL2 trans-splicing revealed by genome-wide analysis of the Trichinella spiralis transcriptome Marius Wenzel2, Christopher Johnston1, Berndt Müller1, Jonathan Pettitt1 and Bernadette Connolly1 Running Title: Conservation of nematode SL2 trans-splicing 1 School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Institute of Medical Sciences, Foresterhill, Aberdeen, AB25 2ZD, UK 2 Centre of Genome-Enabled Biology and Medicine, University of Aberdeen, 23 St Machar Drive, Aberdeen AB24 3RY, UK Corresponding Author: Jonathan Pettitt, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Institute of Medical Sciences, Foresterhill, Aberdeen, AB25 2ZD, UK. Tel.: +44 1224 437516. Email: [email protected] Keywords: spliced leader trans-splicing; polycistronic RNA processing; eukaryotic operons; RNA splicing; nematode genome evolution 1 bioRxiv preprint doi: https://doi.org/10.1101/642082; this version posted May 27, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. ABSTRACT Spliced leader trans-splicing is intimately associated with the presence of eukaryotic operons, allowing the processing of polycistronic RNAs into individual mRNAs. -
Revealing the Missing Expressed Genes Beyond the Human Reference
Chen et al. BMC Genomics 2011, 12:590 http://www.biomedcentral.com/1471-2164/12/590 RESEARCH ARTICLE Open Access Revealing the missing expressed genes beyond the human reference genome by RNA-Seq Geng Chen1, Ruiyuan Li2, Leming Shi3, Junyi Qi1, Pengzhan Hu1, Jian Luo1, Mingyao Liu1 and Tieliu Shi1,4* Abstract Background: The complete and accurate human reference genome is important for functional genomics researches. Therefore, the incomplete reference genome and individual specific sequences have significant effects on various studies. Results: we used two RNA-Seq datasets from human brain tissues and 10 mixed cell lines to investigate the completeness of human reference genome. First, we demonstrated that in previously identified ~5 Mb Asian and ~5 Mb African novel sequences that are absent from the human reference genome of NCBI build 36, ~211 kb and ~201 kb of them could be transcribed, respectively. Our results suggest that many of those transcribed regions are not specific to Asian and African, but also present in Caucasian. Then, we found that the expressions of 104 RefSeq genes that are unalignable to NCBI build 37 in brain and cell lines are higher than 0.1 RPKM. 55 of them are conserved across human, chimpanzee and macaque, suggesting that there are still a significant number of functional human genes absent from the human reference genome. Moreover, we identified hundreds of novel transcript contigs that cannot be aligned to NCBI build 37, RefSeq genes and EST sequences. Some of those novel transcript contigs are also conserved among human, chimpanzee and macaque. By positioning those contigs onto the human genome, we identified several large deletions in the reference genome. -
Coding RNA Genes
Review A guide to naming human non-coding RNA genes Ruth L Seal1,2,* , Ling-Ling Chen3, Sam Griffiths-Jones4, Todd M Lowe5, Michael B Mathews6, Dawn O’Reilly7, Andrew J Pierce8, Peter F Stadler9,10,11,12,13, Igor Ulitsky14 , Sandra L Wolin15 & Elspeth A Bruford1,2 Abstract working on non-coding RNA (ncRNA) nomenclature in the mid- 1980s with the approval of initial gene symbols for mitochondrial Research on non-coding RNA (ncRNA) is a rapidly expanding field. transfer RNA (tRNA) genes. Since then, we have worked closely Providing an official gene symbol and name to ncRNA genes brings with experts in the ncRNA field to develop symbols for many dif- order to otherwise potential chaos as it allows unambiguous ferent kinds of ncRNA genes. communication about each gene. The HUGO Gene Nomenclature The number of genes that the HGNC has named per ncRNA class Committee (HGNC, www.genenames.org) is the only group with is shown in Fig 1, and ranges in number from over 4,500 long the authority to approve symbols for human genes. The HGNC ncRNA (lncRNA) genes and over 1,900 microRNA genes, to just four works with specialist advisors for different classes of ncRNA to genes in the vault and Y RNA classes. Every gene symbol has a ensure that ncRNA nomenclature is accurate and informative, Symbol Report on our website, www.genenames.org, which where possible. Here, we review each major class of ncRNA that is displays the gene symbol, gene name, chromosomal location and currently annotated in the human genome and describe how each also includes links to key resources such as Ensembl (Zerbino et al, class is assigned a standardised nomenclature. -
Long Noncoding Rnas Involvement in Epstein-Barr Virus Infection And
Zhang et al. Virology Journal (2020) 17:51 https://doi.org/10.1186/s12985-020-01308-y REVIEW Open Access Long noncoding RNAs involvement in Epstein-Barr virus infection and tumorigenesis Jing Zhang1,2,3, Xiaohan Li1,2,3, Jingjin Hu1,2,3, Pengfei Cao2, Qijia Yan1,2, Siwei Zhang1,2,3, Wei Dang1,2,3 and Jianhong Lu1,2* Abstract The Epstein-Barr virus (EBV) is a ubiquitous γ-herpesvirus related to various types of cancers, including epithelial nasopharyngeal carcinoma, gastric carcinoma, and lymphoma. Long noncoding RNAs (lncRNAs) are expressed extensively in mammalian cells and play crucial roles in regulating various cellular processes and multiple cancers. Cellular lncRNAs can be differentially expressed induced by EBV infection. The dysregulated lncRNAs probably modulate the host immune response and other biological functions. At present, lncRNAs have been found to be significantly increased or decreased in EBV-infected cells, exosomes and EBV-associated cancers, suggesting their potential function and clinical application as biomarkers. In addition, EBV-encoded lncRNAs, BART and BHLF1 lncRNAs, may play roles in the viral oncogenesis. Analysis of the specific lncRNAs involved in interactions with the EBV machinery will provide information on their potential mechanism of action during multiple steps of EBV tumorigenesis. Here, we review the current knowledge regarding EBV- related lncRNAs and their possible roles in the pathogenesis of EBV-associated cancers. Keywords: Long noncoding RNA, Epstein-Barr virus, Tumorigenesis, Epithelial cancer, Lymphoma Background lymphoma, nasopharyngeal carcinoma (NPC), gastric can- Epstein-Barr virus (EBV) is a ubiquitous γ-herpesvirus, cer (GC), Hodgkin’s disease and breast cancer [1, 2]. -
Caenorhabditis Elegans Mrnas That Encode a Protein Similar to Adars Derive from an Operon Containing Six Genes Ronald F
3424–3432 Nucleic Acids Research, 1999, Vol. 27, No. 17 © 1999 Oxford University Press Caenorhabditis elegans mRNAs that encode a protein similar to ADARs derive from an operon containing six genes Ronald F. Hough, Arunth T. Lingam and Brenda L. Bass* Department of Biochemistry and Howard Hughes Medical Institute, University of Utah, 50 North Medical Drive, Salt Lake City, UT 84132, USA Received June 8, 1999; Revised and Accepted July 15, 1999 DDBJ/EMBL/GenBank accession nos+ ABSTRACT adenosines within base-paired regions of cellular pre-mRNAs and viral RNAs (reviewed in 5). In addition to the C-terminal The Caenorhabditis elegans T20H4.4 open reading domain, which contains the catalytic active site (2,6,7), frame (GenBank accession no. U00037) predicted by ADARs contain variable numbers of an amino acid sequence Genefinder encodes a 367 amino acid protein that is known as the dsRNA binding motif (dsRBM) (8,9). 32–35% identical to the C-terminal domain of adeno- We isolated several T20H4.4 clones from a C.elegans cDNA sine deaminases that act on RNA. We show that library. The cDNAs included two exons in addition to those T20H4.4 cDNAs (GenBank accession no. AF051275) identified as part of the T20H4.4 ORF by Genefinder (10), and encode a larger 495 amino acid protein that is encoded a larger protein (55.3 kDa) that contained a single extended at its N-terminus to include a single double- dsRBM. While one of the newly identified exons was created stranded RNA-binding motif, and that T20H4.4 occu- by conventional cis-splicing, the second derived from a trans- pies the second position in a six-gene operon splicing event since the 5' ends of the three longest clones con- (5'-T20H4.5, T20H4.4, R151.8A, R151.8B, R151.7, tained non-genomic spliced-leader (SL) sequences. -
143.Full.Pdf
Copyright 1999 by the Genetics Society of America The Levels of the RoRNP-Associated Y RNA Are Dependent Upon the Presence of ROP-1, the Caenorhabditis elegans Ro60 Protein Jean-Claude LabbeÂ,* Siegfried Hekimi² and Luis A. Rokeach* *DeÂpartement de Biochimie, Universite de MontreÂal, MontreÂal, QueÂbec H3C 3J7, Canada and ²Biology Department, McGill University, MontreÂal, QueÂbec H3C 3J7, Canada Manuscript received July 15, 1998 Accepted for publication October 5, 1998 ABSTRACT The Ro ribonucleoproteins (RoRNP) consist of at least one major protein of 60 kD, Ro60, and one small associated RNA, designated Y RNA. Although RoRNP have been found in all vertebrate species examined so far, their function remains unknown. The Caenorhabditis elegans rop-1 gene previously has been identi®ed as encoding a Ro60 homologue. We report here the phenotypic characterization of a C. elegans strain in which rop-1 has been disrupted. This is the ®rst report regarding the inactivation of a major RoRNP constituent in any organism. The rop-1 mutant worms display no visible defects. However, at the molecular level, the disruption of rop-1 results in a dramatic decrease in the levels of the ROP-1- associated RNA (CeY RNA). Moreover, transgenic expression of wild-type rop-1 partially rescues the levels of CeY RNA. Considering that transgenes are poorly expressed in the germline, the fact that the rescue is only partial is most likely related to the high abundance of the CeY RNA in the adult germline and in embryos. The developmental expression pattern and localization of CeY RNA suggest a role for this molecule during embryogenesis. -
Why Y Rnas? About Versatile Rnas and Their Functions
Biomolecules 2013, 3, 143-156; doi:10.3390/biom3010143 OPEN ACCESS biomolecules ISSN 2218-273X www.mdpi.com/journal/biomolecules/ Review Why Y RNAs? About Versatile RNAs and Their Functions Marcel Köhn, Nikolaos Pazaitis and Stefan Hüttelmaier * Martin-Luther-University Halle-Wittenberg, Institute of Molecular Medicine, Section Molecular Cell Biology, ZAMED, Heinrich-Damerow-Str.1, D-6120 Halle, Germany; E-Mails: [email protected] (M.K.) [email protected] (N.P.) * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +0049-(0)3455522860; Fax: +0049-(0)3455522894. Received: 31 December 2012; in revised form: 27 January 2013 / Accepted: 31 January 2013 / Published: 8 February 2013 Abstract: Y RNAs constitute a family of highly conserved small noncoding RNAs (in humans: 83-112 nt; Y1, Y3, Y4 and Y5). They are transcribed from individual genes by RNA-polymerase III and fold into conserved stem-loop-structures. Although discovered 30 years ago, insights into the cellular and physiological role of Y RNAs remains incomplete. In this review, we will discuss knowledge on the structural properties, associated proteins and discuss proposed functions of Y RNAs. We suggest Y RNAs to be an integral part of ribonucleoprotein networks within cells and could therefore have substantial influence on many different cellular processes. Putative functions of Y RNAs include small RNA quality control, DNA replication, regulation of the cellular stress response and proliferation. This suggests Y RNAs as essential regulators of cell fate and indicates future avenues of research, which will provide novel insights into the role of small noncoding RNAs in gene expression. -
Mrna Editing, Processing and Quality Control in Caenorhabditis Elegans
| WORMBOOK mRNA Editing, Processing and Quality Control in Caenorhabditis elegans Joshua A. Arribere,*,1 Hidehito Kuroyanagi,†,1 and Heather A. Hundley‡,1 *Department of MCD Biology, UC Santa Cruz, California 95064, †Laboratory of Gene Expression, Medical Research Institute, Tokyo Medical and Dental University, Tokyo 113-8510, Japan, and ‡Medical Sciences Program, Indiana University School of Medicine-Bloomington, Indiana 47405 ABSTRACT While DNA serves as the blueprint of life, the distinct functions of each cell are determined by the dynamic expression of genes from the static genome. The amount and specific sequences of RNAs expressed in a given cell involves a number of regulated processes including RNA synthesis (transcription), processing, splicing, modification, polyadenylation, stability, translation, and degradation. As errors during mRNA production can create gene products that are deleterious to the organism, quality control mechanisms exist to survey and remove errors in mRNA expression and processing. Here, we will provide an overview of mRNA processing and quality control mechanisms that occur in Caenorhabditis elegans, with a focus on those that occur on protein-coding genes after transcription initiation. In addition, we will describe the genetic and technical approaches that have allowed studies in C. elegans to reveal important mechanistic insight into these processes. KEYWORDS Caenorhabditis elegans; splicing; RNA editing; RNA modification; polyadenylation; quality control; WormBook TABLE OF CONTENTS Abstract 531 RNA Editing and Modification 533 Adenosine-to-inosine RNA editing 533 The C. elegans A-to-I editing machinery 534 RNA editing in space and time 535 ADARs regulate the levels and fates of endogenous dsRNA 537 Are other modifications present in C. -
Landscape of the Spliced Leader Trans-Splicing Mechanism In
www.nature.com/scientificreports OPEN Landscape of the spliced leader trans-splicing mechanism in Schistosoma mansoni Received: 12 July 2017 Mariana Boroni1,2, Michael Sammeth 3,4, Sandra Grossi Gava 5, Natasha Andressa Accepted: 12 February 2018 Nogueira Jorge2, Andréa Mara Macedo1, Carlos Renato Machado1, Marina Moraes Mourão5 & Published: xx xx xxxx Glória Regina Franco1 Spliced leader dependent trans-splicing (SLTS) has been described as an important RNA regulatory process that occurs in diferent organisms, including the trematode Schistosoma mansoni. We identifed more than seven thousand putative SLTS sites in the parasite, comprising genes with a wide spectrum of functional classes, which underlines the SLTS as a ubiquitous mechanism in the parasite. Also, SLTS gene expression levels span several orders of magnitude, showing that SLTS frequency is not determined by the expression level of the target gene, but by the presence of particular gene features facilitating or hindering the trans-splicing mechanism. Our in-depth investigation of SLTS events demonstrates widespread alternative trans-splicing (ATS) acceptor sites occurring in diferent regions along the entire gene body, highlighting another important role of SLTS generating alternative RNA isoforms in the parasite, besides the polycistron resolution. Particularly for introns where SLTS directly competes for the same acceptor substrate with cis-splicing, we identifed for the frst time additional and important features that might determine the type of splicing. Our study substantially extends the current knowledge of RNA processing by SLTS in S. mansoni, and provide basis for future studies on the trans-splicing mechanism in other eukaryotes. In contrast to conventional splicing in cis, trans-splicing connects exons of two diferent primary RNA molecules tran- scribed from a priori unrelated genomic loci.